Vitamins
Folic Acid
search
Folic Acid
, Vitamin B9, Folate, Folacin, Folic Acid Supplementation in Pregnancy
See Also
Folate Deficiency
Serum Folate
Macrocytic Anemia
Indications
Supplementation
Pregnancy
Elevated
Homocysteine
levels
Coronary Artery Disease
prevention (disproven)
Physiology
Folate is a precursor to
Tetrahydrofolate
(THF)
Tetrahydrofolate
(THF) is a single carbon (or methyl group) donor important to many reactions
THF donates a methyl group in the formation of
Purine
s (including thymine in DNA)
THF is needed to convert
Glycine
to
Serine
THF is needed to convert
Homocysteine
to
Methionine
(with
Vitamin B12
as a
Cofact
or)
Lowers
Homocysteine
levels (but does not appear to lower CAD risk)
Pharmacokinetics
Folate in supplements is twice as
Bioavailable
as food
Preparations
Sources
Meat
Dark green leafy vegetables
Spinach
Romaine lettuce
Dry beans
Peanuts
Wheat germ
Yeast
Enriched whole cereal grains (140 ug/100 grams grain)
Dosing
Gene
ral
Typical U.S. intake: 50-500 mcg/day
Recommended Daily Allowance (RDA): 400 mcg/day
Coronary Artery Disease
prevention (not recommended)
Folate 400 mcg to 5 mg (depending on
Homocysteine
)
Not recommended due to low efficacy (lowers
Homocysteine
but not CAD risk)
Dosing
Pregnancy
Gene
ral population
Folate 400 mcg (600 Dietary Folate Equivalents or DFE) daily (as found in
Prenatal Vitamin
s)
Start at least 1 month before conception
Continue for at least first 3 months of pregnancy (12 weeks postconceptions)
Typically continued throughout pregnancy and
Lactation
Moderate risk
Folic Acid 1000 mcg (1500 Dietary Folate Equivalents or DFE) daily
Start at least 3 months before conception and continue at least until 12 weeks post-conception
Some guidelines recommend the 4000 to 5000 mcg dose as given to high risk patients (see below)
Indications
Insulin Dependent Diabetes Mellitus
Seizure Disorder
or anticonvulsant use
Obesity
(BMI>35 kg/m2)
Neural Tube Defect
Family History
High risk
Folic Acid 4000-5000 mcg daily
Start at least 3 months before conception and continue at least until 12 weeks post-conception
Indications
Prior
Neural Tube Defect
Folic Acid Antagonist
use (e.g.
Methotrexate
)
Prior delivery complicated by
Folic Acid Deficiency
associated birth defect
Cleft Palate
Congenital Heart Disease
Limb defect
Urinary tract anomaly
Hydrocephalus
Signs
Deficiency
See
Folic Acid Deficiency
See
Macrocytic Anemia
Efficacy
Pregnancy
At conception, reduces
Neural Tube Defect
s by 50%
Spina bifida
Anencephaly
Czeizel (1992) N Engl J Med 327:1832 [PubMed]
Reduced fetal risk of
Cleft Lip
and
Palate
by 25-50%
Lancet (1995) 346:393 [PubMed]
Reduces Conotruncal heart defects by 43%
Transposition of the Great Vessels
Tetralogy of Fallot
Botto (1996) Pediatrics 98:911-7 [PubMed]
Efficacy
Coronary Artery Disease
Possible Protective against cardiovascular disease
Low intake associated with higher
Homocysteine
levels
Higher
Homocysteine
levels associated with CAD, CVA
References
Boushey (1995) JAMA 274:1049 [PubMed]
Malinow (1998) N Engl J Med 338:1009 [PubMed]
References
Johnson (2006) MMWR Recomm Rep 55(RR-6): 1-23 [PubMed]
Wilson (2003) J Obstet Gynaecol Can 25(11):959-73 [PubMed]
Type your search phrase here